Clinical Trials Directory

Trials / Completed

CompletedNCT02376270

Pectin, Aging and Intestinal Barrier Function

The Effects of Pectin on Aging-related Changes in Intestinal Barrier Function, Immune Function and Microbial Composition

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

The population is aging worldwide, which requires more attention to health needs and leads to a dramatic increase in health care costs. Prevention or delay of onset of disorders associated with aging is needed. Dietary intake of pectin, a dietary fiber, may have beneficial effects on gut health parameters, i.e. intestinal barrier function, immune function and microbial composition. As intestinal barrier function may be compromised in the elderly we will investigate whether the effects of pectin on selected parameters of gut health differ between young vs. older individuals. The primary objective of this study is to investigate the effects of aging on pectin-induced changes in intestinal permeability. Furthermore, this study has seven secondary objectives. This study conforms to a randomized, double-blind and placebo-controlled design including two parallel arms.The study population consists of Healthy human volunteers (male and female), 18-40 and 65-75 years old, BMI 20-30 kg/m2. One group will receive 7.5 grams of pectin supplements twice daily for four weeks. A second group will receive 7.5 grams of placebo supplements twice daily for four weeks. Before and after the supplementation period, several measurements will take place. The main study parameter is the change in urinary sugar excretion ratio before and after the intervention period.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPectinThis group will receive 7.5 grams of pectin supplements twice daily for four weeks.
DIETARY_SUPPLEMENTMaltodextrinThis group will receive 7.5 grams of maltodextrin supplements twice daily for four weeks.

Timeline

Start date
2015-03-01
Primary completion
2016-05-01
Completion
2016-05-01
First posted
2015-03-03
Last updated
2016-07-15

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02376270. Inclusion in this directory is not an endorsement.

Pectin, Aging and Intestinal Barrier Function (NCT02376270) · Clinical Trials Directory